Upper Limb Spasticity Clinical Trial
Official title:
An International, Multicentre, Observational, Prospective, Longitudinal Cohort Study to Assess the Impact of Integrated Upper Limb Spasticity Management Including the Use of BoNT-A- Injections on Patient-centred Goal Attainment in Real Life Practice - ULIS III
The primary purpose for this study is to understand the effect of botulinum toxin as a treatment integrated in the management of spasticity (stiffness) in the arm and/or hand, arising from any neurological condition. The study will look at the types of goals that people choose for treatment, and the extent to which these are achieved in different individuals.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04936542 -
A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity.
|
Phase 4 | |
Completed |
NCT00945295 -
Efficacy and Safety Study of Botulinum Neurotoxin A With Rehabilitation Versus Botulinum Neurotoxin A Alone in Treatment of Post-stroke Spasticity
|
N/A | |
Active, not recruiting |
NCT05956509 -
Study of Intramuscular Injections of ABBV-950 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Spasticity
|
Phase 1/Phase 2 | |
Completed |
NCT00465738 -
IncobotulinumtoxinA (Xeomin) for Upper Limb Spasticity
|
Phase 3 | |
Completed |
NCT02321436 -
Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression
|
Phase 4 | |
Completed |
NCT00430196 -
BOTOX® Versus Zanaflex® for the Treatment of Post-Stroke or Traumatic Brain Injury Upper Limb Spasticity
|
Phase 4 | |
Completed |
NCT03821402 -
Efficacy and Safety of DaxibotulinumtoxinA for Injection for the Treatment of Adult Upper Limb Spasticity
|
Phase 2 | |
Terminated |
NCT02888548 -
Randomised, Evaluation-blinded, Crossover, Controlled Study Assessing Dynamic Hand Splinting in Adults With Post-stroke Hemiplegia (Orthox)
|
N/A | |
Completed |
NCT01863901 -
Study Evaluating Treatment of Upper Limb Spasticity Using the Cryo-Touch III Device
|
N/A |